DD102410A5 - - Google Patents

Info

Publication number
DD102410A5
DD102410A5 DD166879A DD16687972A DD102410A5 DD 102410 A5 DD102410 A5 DD 102410A5 DD 166879 A DD166879 A DD 166879A DD 16687972 A DD16687972 A DD 16687972A DD 102410 A5 DD102410 A5 DD 102410A5
Authority
DD
German Democratic Republic
Application number
DD166879A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD102410A5 publication Critical patent/DD102410A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1235—Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1232—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD166879A 1971-11-17 1972-11-15 DD102410A5 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2157148A DE2157148A1 (de) 1971-11-17 1971-11-17 Immunisierungsmittel, verfahren zur herstellung und seine verwendung

Publications (1)

Publication Number Publication Date
DD102410A5 true DD102410A5 (en:Method) 1973-12-12

Family

ID=5825419

Family Applications (1)

Application Number Title Priority Date Filing Date
DD166879A DD102410A5 (en:Method) 1971-11-17 1972-11-15

Country Status (10)

Country Link
JP (1) JPS5512002B2 (en:Method)
AT (1) AT332539B (en:Method)
BE (1) BE791489A (en:Method)
CH (1) CH588867A5 (en:Method)
DD (1) DD102410A5 (en:Method)
DE (1) DE2157148A1 (en:Method)
FR (1) FR2160542B1 (en:Method)
GB (1) GB1416544A (en:Method)
NL (1) NL7215221A (en:Method)
SE (1) SE406419B (en:Method)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3516119A1 (de) * 1985-05-04 1986-11-06 Biotest Pharma GmbH, 6000 Frankfurt Polyvalentes hyperimmunglobulin-praeparat
DE10331974A1 (de) * 2003-07-14 2005-02-17 Uni-Klinikum Schleswig-Holstein Campus Kiel Verfahren zur Herstellung und Verwendung antimikrobielle Proteine induzierender Faktoren
RU2683027C2 (ru) * 2012-12-20 2019-03-26 Заклад Бадавчо-Вдроженёвы Осьродка Сальмонельля "Иммуноляб" Сп. З О.О. Поливалентная иммунизирующая и/или терапевтическая композиция для применения при бактериальных инфекциях или пищевом отравлении, в частности сальмонеллёзе, способ получения этой композиции, её применение и вакцина, содержащая эту композицию

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1468630A (fr) * 1963-03-14 1967-02-10 Taisho Pharmaceutical Co Ltd Préparation du lipide alpha purifié à partir de lipide alpha brut dérivé des lipopolysaccharides de bactéries à gram-négatif

Also Published As

Publication number Publication date
FR2160542B1 (en:Method) 1976-04-23
AU4902772A (en) 1974-05-23
JPS5512002B2 (en:Method) 1980-03-29
AT332539B (de) 1976-10-11
CH588867A5 (en:Method) 1977-06-15
FR2160542A1 (en:Method) 1973-06-29
SE406419B (sv) 1979-02-12
ATA975872A (de) 1976-01-15
DE2157148A1 (de) 1973-05-24
BE791489A (fr) 1973-05-16
GB1416544A (en) 1975-12-03
NL7215221A (en:Method) 1973-05-21
JPS4861621A (en:Method) 1973-08-29

Similar Documents

Publication Publication Date Title
DE2252374B2 (en:Method)
CS150046B1 (en:Method)
FR2123494A1 (en:Method)
DK133804C (en:Method)
FR2160542B1 (en:Method)
FR2122747A5 (en:Method)
FR2120183B1 (en:Method)
FR2083266A5 (en:Method)
FR2122227A5 (en:Method)
FR2124644A5 (en:Method)
FR2121772A1 (en:Method)
FR2123190B1 (en:Method)
CS170838B1 (en:Method)
CS149129B1 (en:Method)
FR2125268A1 (en:Method)
CS153122B1 (en:Method)
CS167519B1 (en:Method)
CS153811B1 (en:Method)
CS151909B1 (en:Method)
CH564646A5 (en:Method)
BG18100A1 (en:Method)
CH564548A5 (en:Method)
BG18340A1 (en:Method)
CH574466A5 (en:Method)
CH559265A5 (en:Method)